<Disease><Name>ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE II: , KANZAKI DISEASE</Name><Synonym>ALPHA-GALACTOSIDASE B; ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY</Synonym><OMIM><Number>609242</Number><URL>http://omim.org/entry/609242</URL></OMIM><Orphanet><Number>79280</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79280</URL></Orphanet><Protein><Number>Alpha-N-acetylgalactosaminidase</Number><URL>http://www.uniprot.org/uniprot/P17050</URL></Protein><ExPASy><Number>3.2.1.49</Number><URL>http://enzyme.expasy.org/EC/3.2.1.49</URL></ExPASy><Gene>22q13.2</Gene><ICD>E77.1</ICD><Summary>rare ;autosomal recessive ;mutation in the gene encoding alpha-N-galactosaminidase (NAGA);type I: Schindler disease, infantile onset neuroaxonal dystrophy ;type II:Kanzaki disease, adult-onset peripheral neuroaxonal degeneration, angiokeratoma corporis diffusum and mild intellectual impairment;type II: intermdiate form</Summary><Symptoms><symtomp><id>2341</id><symptom>angiokeratoma</symptom><category>CARDIOVASCULAR SYSTEM | SKIN</category></symtomp><symtomp><id>1877</id><symptom>cardiomegaly</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1761</id><symptom>coarse facial features</symptom><category>HEAD</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2237</id><symptom>hyperkeratosis</symptom><category>SKIN</category></symtomp><symtomp><id>2246</id><symptom>lymyphedema</symptom><category>SKIN</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3385</id><symptom>skin, abnormal</symptom><category>SKIN</category></symtomp><symtomp><id>1935</id><symptom>vertigo, dizziness</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1085</id><name>alpha-N-Acetylgalactosaminidase</name><specimen>plasma</specimen><value>decreased</value><min>10.70</min><max>28.50</max><unit>nmol/h/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1086</id><name>alpha-N-Acetylgalactosaminidase</name><specimen>fibroblasts</specimen><value>decreased</value><min>94.30</min><max>260.00</max><unit>nmol/h/mg protein</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1087</id><name>alpha-N-Acetylgalactosaminidase</name><specimen>lymphoblasts</specimen><value>decreased</value><min>21.70</min><max>62.90</max><unit>nmol/h/mg protein</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1088</id><name>Glycopeptides</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>965</id><name>Oligosaccharides</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>3609</id><title>Pharmacological chaperones for human alpha-N-acetylgalactosaminidase</title><author>Clark NE,</author><journal>Proc Natl Acad Sci U S A</journal><year>2012</year><book /><volume>109</volume><number>43</number><pages>17400-1740</pages><co_aut>et al.</co_aut></literature><literature><id>2912</id><title>The 1.9 A structure of human alpha-N-acetylgalactosaminidase: The molecular basis of Schindler and Kanzaki diseases</title><author>Clark NE</author><journal>J Mol Biol</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Garman SC</co_aut></literature><literature><id>1621</id><title>Neurologic manifestations of Kanzaki disease</title><author>Umehara F</author><journal>Neurology</journal><year>2004</year><book /><volume>62</volume><number>9</number><pages>1604-1606</pages><co_aut>et al.</co_aut></literature><literature><id>1622</id><title>Mutation analysis of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinomas</title><author>Kanzaki A</author><journal>Anticancer Res</journal><year>2003</year><book /><volume>23</volume><number>2</number><pages>1913-1915</pages><co_aut>et al.</co_aut></literature><literature><id>1623</id><title>Novel mutations in GJB2 encoding connexin-26 in Japanese patients with keratitis-ichthyosis-deafness syndrome</title><author>Yotsumoto S</author><journal>Br J Dermatol</journal><year>2003</year><book /><volume>148</volume><number>4</number><pages>649-653</pages><co_aut>et al.</co_aut></literature><literature><id>1232</id><title>Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: no association with neuroaxonal dystrophy?</title><author>Bakker HD</author><journal>Eur J Hum Genet</journal><year>2001</year><book /><volume>9</volume><number>2</number><pages>91-96</pages><co_aut>et al.</co_aut></literature><literature><id>399</id><title>alpha-N-Acetylgalactosaminidase deficiency: Schindler disease</title><author>Desnick RJ</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2509-2528</pages><co_aut>Wang AM</co_aut></literature><literature><id>403</id><title>Mild phenotype expression of alpha-N-acetylgalactosaminidase deficiency in two adult siblings</title><author>Chabas A</author><journal>J Inherit Metab Dis</journal><year>1994</year><book /><volume>17</volume><number>6</number><pages>724-731</pages><co_aut>et al.</co_aut></literature><literature><id>402</id><title>Lysosomal alpha-N-acetylgalactosaminidase deficiency, the enzymatic defect in angiokeratoma corporis diffusum with glycopeptidur</title><author>Kanzaki T</author><journal>J Clin Invest</journal><year>1991</year><book /><volume>88</volume><number>0</number><pages>707</pages><co_aut>Wang AM, Desnick RJ</co_aut></literature><literature><id>401</id><title>Novel lysosomal glycoaminoacid storage disease with angiokeratoma corporis diffusum</title><author>Kanzaki T</author><journal>Lancet I</journal><year>1989</year><book /><volume>0</volume><number>0</number><pages>875</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>